218 related articles for article (PubMed ID: 1830841)
1. In vitro activity against aerobes and anaerobes of trospectomycin versus spectinomycin.
Gismondo MR; Chisari G; Lo Bue AM
Drugs Exp Clin Res; 1991; 17(2):101-4. PubMed ID: 1830841
[TBL] [Abstract][Full Text] [Related]
2. The comparative activity of twelve 4-quinolone antimicrobials against gram-positive and gram-negative anaerobes.
Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(7):431-4. PubMed ID: 3836865
[TBL] [Abstract][Full Text] [Related]
3. In vitro antibacterial activity of trospectomycin (U-63,366F) against anaerobic bacteria and aerobic gram-positive cocci in Chile.
Montiel F; Kaltwasser G; Pinto ME; Lam M
Diagn Microbiol Infect Dis; 1991; 14(3):259-64. PubMed ID: 1832369
[TBL] [Abstract][Full Text] [Related]
4. The in vitro activity of trospectomycin against anaerobic bacteria.
Chisari G; Lo Bue AM; Nicoletti G
J Chemother; 1995 Dec; 7(6):515-8. PubMed ID: 8667035
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of imipenem against gram-positive and gram-negative aerobic bacteria from clinical isolates.
Bastianini L; Sposini T; Bartoli A; Marconi P
Microbiologica; 1988 Apr; 11(2):137-42. PubMed ID: 3165489
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
Klietmann W; Focht J; Nösner K
Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam.
Appelbaum PC; Spangler SK; Jacobs MR
J Antimicrob Chemother; 1993 Aug; 32(2):223-31. PubMed ID: 8226424
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of in vitro activity of teicoplanin against recent clinical isolates.
Nani E; Amato G; Anzivino D; Covelli B; Lembo M
Chemioterapia; 1988 Feb; 7(1):20-3. PubMed ID: 2967737
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro study of the antibacterial effect of cefotetan against gram-positive and gram-negative aerobic and anaerobic strains from fresh clinical isolates.
Klietmann W; Focht J; Nösner K
Chemioterapia; 1987 Jun; 6(2 Suppl):92-3. PubMed ID: 3509542
[No Abstract] [Full Text] [Related]
10. In vitro activity of the combination trimethoprim plus sulfamethoxazole compared with that of other chemotherapeutic agents.
Focht J; Klietmann W; Nösner K
Arzneimittelforschung; 1988 Aug; 38(8):1085-8. PubMed ID: 3264166
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27247 Gram-positive and Gram-negative aerobic isolates: a global surveillance study.
Bouchillon SK; Hoban DJ; Johnson JL; Johnson BM; Butler DL; Saunders KA; Miller LA; Poupard JA
Int J Antimicrob Agents; 2004 Feb; 23(2):181-96. PubMed ID: 15013045
[TBL] [Abstract][Full Text] [Related]
12. [The study of drug resistance in aerobic and anaerobic bacterial flora to selected antibacterial drugs].
Michalska W; Chylak J; Pietkiewicz K
Med Dosw Mikrobiol; 1996; 48(1-2):61-70. PubMed ID: 8926770
[TBL] [Abstract][Full Text] [Related]
13. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
[TBL] [Abstract][Full Text] [Related]
14. Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testing.
Hecht DW
Anaerobe; 2006 Jun; 12(3):115-21. PubMed ID: 16765857
[No Abstract] [Full Text] [Related]
15. [Synthesis and antibacterial activity of dl-7-(4,4-dimethyl-3-aminomethylpyrrolidinyl) -quinolones].
Wang YC; Wang XY; Liu JY; Guo HY
Yao Xue Xue Bao; 2006 Jan; 41(1):58-64. PubMed ID: 16683529
[TBL] [Abstract][Full Text] [Related]
16. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.
Alhanout K; Brunel JM; Raoult D; Rolain JM
J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity, effects of modifying in vitro testing parameters and optimization of disc diffusion tests.
Jones RN; Fritsche TR; Ge Y; Kaniga K; Sader HS
J Antimicrob Chemother; 2005 Dec; 56(6):1047-52. PubMed ID: 16239290
[TBL] [Abstract][Full Text] [Related]
18. Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci.
Drabu YJ; Blakemore PH
Drugs Exp Clin Res; 1990; 16(11):557-63. PubMed ID: 2151661
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of tigecycline against clinical isolates from Shanghai, China.
Zhang YY; Zhou L; Zhu DM; Wu PC; Hu FP; Wu WH; Wang F
Diagn Microbiol Infect Dis; 2004 Dec; 50(4):267-81. PubMed ID: 15582300
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of tigecycline against recently isolated Gram-negative anaerobic bacteria in Greece, including metronidazole-resistant strains.
Katsandri A; Avlamis A; Pantazatou A; Petrikkos GL; Legakis NJ; Papaparaskevas J;
Diagn Microbiol Infect Dis; 2006 Jul; 55(3):231-6. PubMed ID: 16626904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
